Does DARBEPOETIN ALFA Cause Neoplasm malignant? 190 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 190 reports of Neoplasm malignant have been filed in association with DARBEPOETIN ALFA (ARANESP). This represents 0.6% of all adverse event reports for DARBEPOETIN ALFA.
190
Reports of Neoplasm malignant with DARBEPOETIN ALFA
0.6%
of all DARBEPOETIN ALFA reports
63
Deaths
114
Hospitalizations
How Dangerous Is Neoplasm malignant From DARBEPOETIN ALFA?
Of the 190 reports, 63 (33.2%) resulted in death, 114 (60.0%) required hospitalization, and 2 (1.1%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DARBEPOETIN ALFA. However, 190 reports have been filed with the FAERS database.
What Other Side Effects Does DARBEPOETIN ALFA Cause?
Death (12,264)
Hospitalisation (5,682)
Product storage error (1,619)
Off label use (1,586)
Circumstance or information capable of leading to medication error (1,050)
Haemodialysis (907)
Pneumonia (733)
Fall (726)
Anaemia (562)
Dialysis (555)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which DARBEPOETIN ALFA Alternatives Have Lower Neoplasm malignant Risk?
DARBEPOETIN ALFA vs DARIDOREXANT
DARBEPOETIN ALFA vs DARIFENACIN HYDROBROMIDE
DARBEPOETIN ALFA vs DAROLUTAMIDE
DARBEPOETIN ALFA vs DARUNAVIR
DARBEPOETIN ALFA vs DARUNAVIR ETHANOLATE